Skip to content

Author

Meeqaat H. Altrufi

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression

Topical febuxostat demonstrated significant antipsoriatic effects in the imiquimod-induced mouse model of psoriasiform dermatitis, accompanied by improvements in oxidative stress, inflammatory cytokines, and histopathological abnormalities, which support further investigation of topical febuxostat as a potential nonste...

H. T. Alamir, W. Albahadly, H. F. Al-zubaidy et al. · 0 citations
Open access Aug 2026

Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling

Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis.

W. Albahadly, M. Rasool, H. Al-Saedi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.